which glp 1 agonists have cardiovascular benefit GLP-1 drugs improve liver and heart health Frontiers | Glucagon-like peptide-1 receptor

Diabetes 39 , S148S154 (2015)

M.FriasJ

In the recently published BARI-OPTIMISE double-blind, placebo-controlled trial, 70 patients post-SG or RYGB who were tested and found to have insufficient GLP-1 response to meal stimulation were randomized to receive liraglutide (3 mg/day) or placebo, in addition to lifestyle interventions [49]

Common side effects of liraglutide (as well as brand-name Victoza and Saxenda) include: Nausea Vomiting Upset stomach Diarrhea or constipation Decreased appetite Compounded GLP-1s vs

Knapen (86) also reported through follow-up studies that the pancreatic tumor risk in patients treated with GLP-1RA for a long period of time was not significantly different